Suppression of apoptotic cell death by hepatitis C virus core protein

Virology

Volumn 226, Issue 2, 1996, Pages 176-182

  Ray, Ratna B ^a   Meyer, Keith ^a   Ray, Ranjit ^a,b  

^a SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b S LOUIS UNIV HLTH SCIENCES CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; CORE PROTEIN;

ANIMAL CELL; APOPTOSIS; ARTICLE; CARCINOGENICITY; CELL DEATH; HAMSTER; HEPATITIS C VIRUS; HUMAN; HUMAN CELL; IRRADIATION; LIVER CELL CARCINOMA; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL;

EID: 0030589563     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1006/viro.1996.0644     Document Type: Article

References (49)

1. Bissonnette, R. P., Fernando, E., Mahboubi, A., and Green, D. R. (1992). Apoptotic cell death induced by c-myc is inhibited by bcl-2. Nature 359, 552-554.
2. Bukh, J., Purcell, R. H., and Miller, R. H. (1994). Sequence analysis of the core gene of 14 hepatitis C virus genotypes. Proc. Natl. Acad. Sci. USA 91, 8239-8243.
3. Cerny, A., and Chisari, F. V. (1994). Immunological aspects of HCV infection. Intervirology 37, 119-125.
4. Chien, D. Y., Choo, Q. L., Ralston, R., Spaete, R., Tong, M., Houghton, M., and Kuo, G. (1993). Persistence of HCV despite antibodies to both putative envelope glycoproteins. Lancet 342, 933.
5. Choo, Q. L., Kuo, G., Weiner, A. J., Overby, L. R., Bradley, D. W., and Houghton, M. (1989). Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome. Science 244, 359-362.
6. Di Bisceglie, A. M. (1995). Hepatitis C and hepatocellular carcinoma. Semin. Liver Dis. 15, 64-69.
7. Doria, M., Klein, N., Lucito, R., and Schneider, R. J. (1995). The hepatitis B virus HBx protein is a dual specificity cytoplasmic activator of Ras and nuclear activator of transcription factors. EMBO J. 14, 4747-4757.
8. Erickson, A. L., Houghton, M., Choo, Q. L., Weiner, A. J., Ralston, R., Muchmore, E., and Walker, C. M. (1993). Hepatitis C virus-specific CTL responses in the liver of chimpanzees with acute and chronic hepatitis C. J. Immunol. 151, 4189-4199.
9. Farci, P., Alter, H. J., Wong, D. C., Miller, R. H., Govindarajan, S., Engle, R., Shapiro, M., and Purcell, R. H. (1994). Prevention of hepatitis C virus infection in chimpanzees after antibody-mediated in vitro neutralization. Proc. Natl. Acad. Sci. USA 91, 7792-7796.
10. Fritsche, M., Haessler, C., and Brandner, G. (1993). Induction of nuclear accumulation of the tumor-suppressor protein p53 by DNA-damaging agents. Oncogene 8, 307-318.
11. Gerber, M. A. (1995). Pathobiologic effects of hepatitis C. J. Hepatol. 22, 83-86.
12. Grakoui, A., Wychowski, C., Lin, C., Feinstone, S. M., and Rice, C. M. (1993a). Expression and identification of hepatitis C virus polyprotein cleavage products. J. Virol. 67, 1385-1395.
13. Grakoui, A., McCourt, D. W., Wychowski, C., Feinstone, S. M., and Rice, C. M. (1993b). Characterization of the hepatitis C virus-encoded serine proteinase: Determination of proteinase-dependent polyprotein cleavage sites. J. Virol. 67, 2832-2843.
14. Hijikata, M., Kato, N., Ootsuyama, Y., Nakagawa, M., and Shimotohno, K. (1991). Gene mapping of the putative structural region of the hepaitits C virus genome by in vitro processing analysis. Proc. Natl. Acad. Sci. USA 88, 5547-5551.
15. Hsu, I. C., Metcalf, R. A., Sun, T., Welsh, J. A., Wang, N. J., and Harris, C. C. (1991). Mutational hotspot in the p53 gene in human hepatocellular carcinomas. Nature 350, 427-428.
16. Ito, T., Mukaigawa, J., Zuo, J., Hirabayashi, Y., Mitamura, K., and Yasuli, K. (1996). Cultivation of hepatitis C virus in primary hepatocyte culture from patients with chronic hepatitis C results in release of high titre infectious virus. J Gen. Virol. 77, 1043-1054.
17. The Jordan Report. (1995). Division of Microbiology and Infectious Diseases, National Institutes of Health, Bethesda, Maryland.
18. Kuo, G., Choo, Q. L., Alter, H. J., Gitnick, G. L., Redekar, A. G., Purcell, R. H., Miyamura, T., Dienstag, J. L., Alter, M. J., Lee, W. S., Kuo, C., Berger, K., Shuster, J. R., Overby, L. R., Bradley, D. W., and Houghton, M. (1989). An assay for circulating antibodies to a major etiologic virus of human non-A, non-B hepatitis. Science 244, 362-364.
19. Lagging, L. M., Meyer, K., Hoft, D., Houghton, M., Belshe, R. B., and Ray, R. (1995). Immune responses to plasmid DNA encoding the hepatitis C virus core protein. J Virol. 69, 5859-5863.
20. Lane, D. P. (1992). Cancer: p53 guardian of the genome. Nature 358, 15-16.
21. Lanford, R. E., Notvall, L., Chavez, D., White, R., Frenzel, G., Simonsen, C., and Kim, J. (1993). Analysis of hepatitis C virus capsid, E1, and E2/NS1 proteins expressed in insect cells. Virology 197, 225-235.
22. Levine, A. J. (1993). The tumor suppressor genes. Annu. Rev. Biochem. 62, 623-651.
23. Lo, S.-Y., Masiarz, F., Hwang, S. B., Lai, M. C., and Ou, J.-H. (1995). Differential subcellular localization of hepatitis C virus core gene products. Virology 213, 455-461.
24. Lo, S.-Y., Selby, M. J., and Ou, J.-H. (1996). Interaction between hepatitis C virus core protein and E1 envelope protein. J. Virol. 70, 5177-5182.
25. Matsumoto, M., Hwang, S. B., Jeng, K. S., Zhu, N., and Lai, M. M. C. (1996). Homotypic interaction and multimerization of hepatitis C virus core protein. Virology 218, 43-51.
26. Purcell, R. H. (1994). Hepatitis viruses: Changing patterns of human disease. Proc. Natl. Acad. Sci. USA 91, 2401-2406.
27. Rao, L., Debbas, M., Sabbatini, P., Hecenbery, D., Korsmeyer, D., and White, E. (1992). The adenovirus E1A proteins induced apoptosis, which is inhibited by the E1B 19kDa and bc1-2 proteins. Proc. Natl. Acad. Sci. USA 89, 7742-7746.
28. Ravaggi, A., Natoli, G., Primi, D., Albertini, A., Levrero, M., and Cariani, E. (1994). Intracellular localization of full-length and truncated hepatitis C virus core protein expressed in mammalian cells. J. Hepatol. 20, 833-836.
29. Ray, R., Khanna, A., Lagging, L. M., Meyer, K., Choo, Q. L., Ralston, R., Houghton, M., and Becherer, P. R. (1994). Peptide immunogen mimicry of putative E1 glycoprotein specific epitopes in hepatitis C virus. J. Virol. 68, 4420-4426.
30. Ray, R. B., Lagging, L. M., Meyer, K., Steele, R., and Ray, R. (1995). Transcriptional regulation of cellular and viral promoters by the hepatitis C virus core protein. Virus Res. 37, 209-220.
31. Ray, R. B. (1995). Induction of cell death in murine fibroblasts by a c-myc promoter binding protein. Cell Growth Differ. 6, 1089-1096.
32. Ray, R. B., Lagging, L. M., Meyer, K., and Ray, R. (1996). Hepatitis C virus core protein cooperates with ras and transforms primary rat embryo fibroblasts to tumorigenic phenotype. J. Virol. 70, 4438-4443.
33. Rose, D., Campagnoli, S., Moretto, C., Guenzi, E., Cousens, L., Chin, M., Dong, C., Weiner, A. J., Lau, J. Y. N., Choo, Q., Chien, D., Pileri, P., Houghton, M., and Abrignani, S. (1996). A quantitative test to estimate neutralizing antibodies to the hepatitis C virus: Cytofluorimetric assessment of envelope glycoprotein 2 binding to target cells. Proc. Natl. Acad. Sci. USA 93, 1759-1763.
34. Santolini, E., Migliaccio, G., and La Monica, N. (1994). Biosynthesis and biochemical properties of the hepatitis C virus core protein. J. Virol. 68, 3631-3641.
35. Selby, M. J., Choo, Q. L., Berger, K., Kuo, G., Glazer, E., Eckart, M., Lee, C., Chien, D., Kuo, C., and Houghton, M. (1993). Expression, identification and subcellular localization of the proteins encoded by the hepatitis C viral genome. J. Gen. Virol. 74, 1103-1113.
36. Shih, C. M., Lo, S. J., Miyamura, T., Chen, S. Y., and Lee, Y. W. (1993). Suppression of hepatitis B virus expression and replication by hepatitis C virus core protein in HuH-7 cells. J. Virol. 67, 5823-5832.
37. Shirai, M., Okada, H., Nishioka, M., Akatsuka, T., Wychowski, C., Houghten, R., Pendleton, C. D., Feinstone, S. M., and Berzofsky, J. A. (1994). An epitope in hepatitis C virus core region recognized by cytotoxic T cells in mice and humans. J. Virol. 68, 3334-3342.
38. Strasser, A., Harris, A. W., Jacks, T., and Cory, S. (1994). DNA damage can induce apoptosis in proliferating lymphoid cells via p53-independent mechanisms inhibitable by Bc1-2. Cell 79, 329-339.
39. Subramanian, T., Boyd, J. M., and Chinnadurai, G. (1995). Functional substitution identifies a cell survival promoting domain common to adenovirus E1B 19kDa and Bc1-2 proteins. Oncogene 11, 2403-2409.
40. Suzuki, R., Matsuura, Y., Suzuki, T., Ando, A., Chiba, J., Harada, S., Saito, I., and Miyamura, T. (1995). Nuclear localization of the truncated hepatitis C virus core protein with its hydrophobic C terminus deleted. J. Gen. Virol. 76, 53-61.
41. Symonds, H., Krall, L., Remington, L., Saenz-Robles, M., Lowe, S., Jacks, T., and VanDyke, T. (1994). p53-dependent apoptosis suppresses tumor growth and progression in vivo. Cell 78, 703-711.
42. Thompson, C. B. (1995). Apoptosis in the pathogenesis and treatment of disease. Science 267, 1456-1462.
43. Ueda, K., and Ganem, D. (1996). Apoptosis is induced by N-myc expression in hepatocytes, a frequent event in hepadnavirus oncogeneiss, and is blocked by insulin-like growth factor II. J. Virol. 70, 1375-1383.
44. Vaux, D. L., and Strasser, A. (1996). The molecular biology of apoptosis. Proc. Natl. Acad. Sci. USA 93, 2239-2244.
45. Wagner, A. J., Kokontis, J. M., and Hay, N. (1994). Myc-mediated apoptosis requires wild-type p53 in a manner independent of cell cycle arrest and the ability of p53 to induce p21 waf1/cip1. Gene Dev. 8, 2817-2830.
46. Wang, X. W., Gibsom, M. K., Vermeulen, W., Yeh, H., Forrester, K., Sturzbecher, H-W., Hoeijmakers, J. H. J., and Harris, C. C. (1995). Abrogation of p53-induced apoptosis by the hepatitis B virus X gene. Cancer Res. 55, 6012-6016.
47. White, E. (1996). Life, death, and the pursuit of apoptosis. Gene Dev. 10, 1-15.
48. Zanotto, P. M. A., Gibbs, M. J., Gould, E. A., and Holmes, E. C. (1996). A reevaluation of the higher taxonomy of viruses based on RNA polymerases. J. Virol. 70, 6083-6096.
49. Zhu, H., Shen, Y., and Shenk, T. (1995). Human cytomegalovirus IE1 and IE2 proteins block apoptosis. J. Virol. 69, 7960-7070.